Skip to main content
. 2013 May 31;2013(5):CD004525. doi: 10.1002/14651858.CD004525.pub2

46.28. Analysis.

46.28

Comparison 46 Adverse events within two years: etanercept + disease‐modifying anti‐rheumatic drug (DMARD) vs. etanercept, Outcome 28 Upper respiratory tract infection.